Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    Open Studies | "Candidiasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Candidiasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Invasive Candidiasis in ICU
Condition: Invasive Candidiasis
Intervention:
2 Recruiting CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Condition: Candidiasis, Chronic Mucocutaneous
Intervention: Drug: Amphotericin B
3 Recruiting Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition: Candidiasis, Invasive
Interventions: Drug: Caspofungin;   Drug: Amphotericin B Deoxycholate
4 Not yet recruiting Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis
Condition: Vulvovaginal Candidiasis
Interventions: Device: LactiSal vaginal gel 1%;   Device: LactiSal vaginal tablet 50mg;   Drug: Clotrimazole vaginal tablet 100mg
5 Recruiting Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis
Condition: Vulvo-vaginal Candidiasis
Interventions: Dietary Supplement: Saccharomyces cerevisiae;   Dietary Supplement: Placebo
6 Not yet recruiting Fluconazole Versus Micafungin in Neonates With Candidiasis
Condition: Candidiasis
Interventions: Drug: Fluconazole;   Drug: Micafungin
7 Recruiting Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.
Condition: Invasive Candidiasis; Treatment With Echinocandin
Interventions: Biological: Blood sample taken on the day the treatment is initiated;   Biological: Blood sample taken on day 3 after initiation of treatment;   Biological: Blood sample taken on day 5 after initiation of;   Biological: Blood sample taken on day 7 after initiation of treatment;   Biological: Blood sample taken on day 10 after initiation of treatment
8 Unknown  Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis
Conditions: Candidiasis;   Bacterial Vaginosis
Interventions: Drug: Clindamycin 100mg and Ketoconazole 400mg;   Drug: Tetracycline 100mg and Amphotericin B 50mg
9 Recruiting Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
Conditions: Invasive Fungal Disease;   Chronic Disseminated Candidiasis;   Hematological Malignancies;   Hematopoietic Stem Cell Transplantation;   Neutropenia
Intervention: Device: 18F-FDG PET Scan
10 Unknown  A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China
Condition: Candidiasis
Intervention:
11 Not yet recruiting A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.
Condition: Oropharyngeal Candidiasis
Interventions: Drug: Unique Pharmaceutical Laboratories, India;   Drug: Roxane Laboratories Inc., USA
12 Recruiting RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
Conditions: Candidiasis, Vulvovaginal;   Mycoses;   Yeast Infection;   Moniliasis, Vulvovaginal;   Vaginitis, Monilial
Interventions: Drug: CD101 gel (3%);   Drug: CD101 gel (1%);   Drug: CD101 ointment (6%);   Drug: CD101 ointment (1%);   Drug: Fluconazole
13 Recruiting Pharmacokinetics of Micafungin in Critically Ill Patients
Conditions: Critical Illness;   Invasive Candidiasis
Intervention:
14 Recruiting Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
Conditions: Microbiome;   Antibiotic-Induced VVC;   Vaginal Candidiasis
Intervention:
15 Recruiting Studies of Disorders With Increased Susceptibility to Fungal Infections
Conditions: Primary Immune Deficiency;   Candida;   Autoimmune Polyendocrinopathy Candidiasis Ectodermal;   Chronic Mucocutaneous Candidiasis (CMC);   Fungal Infection
Intervention:
16 Recruiting Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis
Condition: Candidiasis, Vulvovaginal
Interventions: Device: Saccharomyces cerevisiae;   Device: Placebo
17 Recruiting PEACE: Pediatric Antifungal Comparative Effectiveness
Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
18 Not yet recruiting Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients
Condition: Candida Infections
Intervention:
19 Recruiting Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections
Conditions: Candidiasis;   Vaginosis, Bacterial
Interventions: Device: Boric acid and probiotics;   Drug: Antibiotic (Clindamycin);   Drug: Antifungal (Clotrimazole)
20 Unknown  Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
Condition: Pulmonary Candidiasis
Intervention: Drug: fluconazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years